NL
RGNX icon

NKCFO LLC’s Regenxbio RGNX Stock Holding History

NKCFO LLC’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,500
Closed -$116K – 123
2022
Q1 		$116K Buy
+3,500
New +$97.2K 0.04% 82

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

NKCFO LLC's RGNX Position: Q2 2022 in Review

NKCFO LLC sold out of Regenxbio (RGNX) in Q2 2022, closing a stake of 3,500 shares — an estimated $116K sold.

NKCFO LLC first reported a position in RGNX in Q1 2022 and held it in 1 quarter. The position peaked at $116K in Q1 2022. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2022.

  • NKCFO LLC reported no remaining Regenxbio position as of Q2 2022 after selling out during the quarter.
  • NKCFO LLC sold 3,500 Regenxbio shares in Q2 2022, an estimated $116K.
  • NKCFO LLC first reported a position in Regenxbio in Q1 2022 and held it in 1 quarter.
  • NKCFO LLC's Regenxbio position peaked at $116K in Q1 2022.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2022.

Based on NKCFO LLC's 13F filing for Q2 2022, filed 8 Jul 2022.